Mesothelin-targeted alpha therapy in PDAC with [225Ac]Ac-Macropa-PEG6-Amatuximab

Nuclear Medicine and Biology 2026

View at publisher
Authors: Syed Sibtain Hussain Shah, Ralph Santos-Oliveira, Madeeha Shabnam, DeryaIlem-Ozdemir
DOI: 10.1016/j.nucmedbio.2026.109606
Cited by: 2
References: 33

Fields of Study & Subjects

Radiopharmaceutical Chemistry and Applications Neuroendocrine Tumor Research Advances Immunotherapy and Immune Responses

Publication details

Journal / source
Nuclear Medicine and Biology
Publisher
Elsevier BV
Volume
154-155
Pages
109606–109606
Publication date
28 January 2026
Language
EN